Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment

Circulation

Volumn 95, Issue 5, 1997, Pages 1301-1307

  Oparil, Suzanne ^a,b   Levine, Ronald L ^a   Chen, Shi Juan ^a   Durand, Joan ^a   Chen, Y F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b 1034 Zeigler Research Bldg   (United States)

Author keywords

carotid arteries; endothelium; hormones; muscle, smooth; restenosis; sex; women

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; SEX DIFFERENCE; VASCULAR SMOOTH MUSCLE;

EID: 0031037165     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.5.1301     Document Type: Article

References (13)

1. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J. 1987;114:1467-1503.
2. Bush TL, Barrett-Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev. 1985;7:89-104.
3. Knopp RH. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet Gynecol. 1988;72(suppl 5):23S-30S.
4. Riedel M, Rafflenbeul W, Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin Invest. 1993;71:406-412.
5. Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
6. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
7. Oparil S, Levine RL, Chen YF. Sex hormones and the vasculature. In: Sowers JR, Walsh M, eds. Endocrinology of the Vasculature. Totwa, NJ: Humana Press, Inc; 1996:225-237.
8. The Coronary Drug Project Research Group. The Coronary Drug Project: initial findings leading to modifications of its research protocol. JAMA. 1970;214:1303-1313.
9. The Coronary Drug Project Research Group. The Coronary Drug Project: findings leading to discontinuation of the 2.5 mg/day estrogen group. JAMA. 1973;226:652-657.
10. Chen SJ, Li H, Durand J, Oparil S, Chen YF. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 1996;93:577-584.
11. Levine RL, Chen SJ, Durand J, Chen YF, Oparil S. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation. 1996;94:2221-2227.
12. Legan SJ, Coon GA, Karsch FJ. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology. 1975;96:50-56.
13. Foegh M, Asotra S, Howell M, Ramwell P. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vase Surg. 1994;19:722-726.